1. Home
  2. GKOS vs CPT Comparison

GKOS vs CPT Comparison

Compare GKOS & CPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$185.49

Market Cap

10.9B

Sector

Health Care

ML Signal

N/A

Logo Camden Property Trust

CPT

Camden Property Trust

N/A

Current Price

$110.40

Market Cap

11.3B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
GKOS
CPT
Founded
1998
1993
Country
United States
United States
Employees
1094
N/A
Industry
Medical/Dental Instruments
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
10.9B
11.3B
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
GKOS
CPT
Price
$185.49
$110.40
Analyst Decision
Strong Buy
Buy
Analyst Count
12
17
Target Price
$126.92
$115.28
AVG Volume (30 Days)
855.1K
942.0K
Earning Date
04-29-2026
04-30-2026
Dividend Yield
N/A
4.03%
EPS Growth
N/A
136.00
EPS
N/A
0.59
Revenue
$507,442,000.00
$12,967,000.00
Revenue This Year
$23.32
N/A
Revenue Next Year
$27.43
$2.60
P/E Ratio
N/A
$187.27
Revenue Growth
32.33
81.69
52 Week Low
$73.16
$96.53
52 Week High
$189.69
$119.81

Technical Indicators

Market Signals
Indicator
GKOS
CPT
Relative Strength Index (RSI) 74.68 46.49
Support Level $99.75 $108.46
Resistance Level N/A $111.82
Average True Range (ATR) 7.77 2.14
MACD 1.39 -0.29
Stochastic Oscillator 88.29 32.93

Price Performance

Historical Comparison
GKOS
CPT

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About CPT Camden Property Trust

Camden Property Trust is a real estate investment trust engaged in the ownership, management, development, reposition, redevelopment, acquisition, and construction of multifamily apartment communities. It owned interests in, operated, or developing nearly 175 multifamily properties comprised of nearly 59,921 apartment homes across the United States.

Share on Social Networks: